Latest Shareholder Approvals News

Talonx Resources (ASX: TXR) reported robust drilling results at its Viking and Blair North gold projects, highlighting a high-grade shallow oxide gold zone at Viking’s Beaker 2 prospect. The company also advanced exploration and licence renewal efforts at its Kihabe zinc-lead-silver project in Botswana, closing the quarter with $0.72 million cash.

Finder Energy has secured key regulatory approval for its KTJ Project in Timor-Leste and raised $27 million to advance development, positioning for a Final Investment Decision in Q3 2026.

Tennant Minerals has confirmed robust high-grade copper-gold-bismuth mineralisation at its Bluebird discovery, extending the resource down-plunge and westward. The company secured $2.8 million in funding to accelerate drilling and development.

Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.

Lac Gold Limited's latest drilling at the Rouyn Gold Project reveals extensive high-grade gold mineralisation, while the acquisition of the historic Golden Patricia Mine adds a significant growth platform. The company ends the quarter with $13.3 million in cash and a clear focus on resource expansion.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

Connected Minerals has secured shareholder and regulatory approvals to acquire Frontier Group, gaining an 80% stake in Angola’s Bailundo Carbonatite Project with expanded mineral rights including niobium and rare earths. Completion is imminent as exploration activities ramp up.

Odessa Minerals has reported encouraging exploration results at its WA projects, confirming potential carbonatite-hosted rare earth elements and new base metal anomalies, while securing $2.65 million in fresh capital to fund a maiden 10,000m drilling campaign and project acquisitions.

Comet Ridge has completed a $40.9 million capital raise combining a Share Purchase Plan and a two-tranche placement to fund full acquisition and development of its Mahalo Gas Project.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.

Patagonia Lithium (ASX:PL3) reported solid progress in its June quarter, hitting key milestones in drilling, pump testing, and resource modelling at its Argentine lithium brine projects, supported by a strong cash position following recent capital raises.